Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases

© 2022, Bi et al..

IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

eLife - 11(2022) vom: 03. Aug.

Sprache:

Englisch

Beteiligte Personen:

Bi, Yanxia [VerfasserIn]
Su, Jian [VerfasserIn]
Zhou, Shengru [VerfasserIn]
Zhao, Yingjie [VerfasserIn]
Zhang, Yan [VerfasserIn]
Zhang, Huihui [VerfasserIn]
Liu, Mingdong [VerfasserIn]
Zhou, Aiwu [VerfasserIn]
Xu, Jianrong [VerfasserIn]
Pan, Meng [VerfasserIn]
Zhao, Yiming [VerfasserIn]
Li, Fubin [VerfasserIn]

Links:

Volltext

Themen:

ADAMTS13
Autoantibodies
Autoantibody
Desmoglein 1
Fc-FcγR interaction
Human
IgG4
Immunoglobulin G
Immunology
Inflammation
Journal Article
Mouse
Receptors, IgG
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 19.08.2022

Date Revised 07.09.2022

published: Electronic

Citation Status MEDLINE

doi:

10.7554/eLife.76223

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM344401987